Genmark Diagnostics Stock

Genmark Diagnostics EV/EBIT

Delisted

The EV/EBIT (Enterprise Value to EBIT) of Genmark Diagnostics (GNMK) as of Aug 15, 2026 is -95.31. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -37.42 — a change of 154.73% (lower).

EV/EBIT

-95.31

YoY

154.73%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Genmark Diagnostics is 2026 -95.31 . EV/EBIT (Enterprise Value to EBIT) of Genmark Diagnostics was 2025 -37.42 . It decreases by 154.73% lower compared to the previous year.

The Genmark Diagnostics EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2018
0.00 base
Jan 1, 2019
0.00 base
Jan 1, 2020
0.00 base
Jan 1, 2021 (e)
0.00 base
Jan 1, 2022 (e)
0.00 base
Jan 1, 2023 (e)
0.00 base
Jan 1, 2024 (e)
0.00 base
Jan 1, 2025 (e)
0.00 base
YEARPRICE-TO-EBIT
2025 est -
2024 est -
2023 est -
2022 est -
2021 est -
2020 -
2019 -
2018 -
2017 -
2016 -
2015 -
2014 -
2013 -
2012 -
2011 -
2010 -
2009 -
2008 -
Access this data via the Eulerpool API
Get Free API Key

Genmark Diagnostics Stock analysis

What does Genmark Diagnostics do? The company Genmark Diagnostics was founded in 1999 in California, USA. Its goal is to develop and produce diagnostic and testing solutions for the medical and biotechnology industries, with a focus on microfluidic technology. The company offers comprehensive services from the development of diagnostic and testing solutions to the production of devices and systems. Its main business areas are molecular diagnostics, laboratory test automation, and genomics. Genmark Diagnostics provides a variety of test solutions for diseases in the field of molecular diagnostics, as well as automation platforms for laboratory testing and products for genomic analysis. The company's products, such as the ePlex® system, aim to improve the accuracy and speed of medical diagnostics. Genmark Diagnostics is headquartered in Carlsbad, California, USA and has international branches. Its mission is to enhance the accuracy and speed of medical diagnostics worldwide through innovative devices and systems. Genmark Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmark Diagnostics stock

EV/EBIT (Enterprise Value to EBIT) of Genmark Diagnostics is -95.31 in 2026.

EV/EBIT (Enterprise Value to EBIT) of Genmark Diagnostics changed from -37.42 to -95.31, representing a 154.73% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Genmark Diagnostics since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Genmark Diagnostics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API
Get Free API Key

Valuation — Genmark Diagnostics

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Genmark Diagnostics